Method of supporting a diagnosis of a risk of cancer recurrence, and a device of supporting a diagnosis of a risk of cancer recurrence
AssigneeSysmex Corporation
InventorsMasaki Shibayama, Hideki Ishihara, Tomoko Matsushima, Shigehiro Numada
Life of this patent
Estimating the term…
Abstract
A method of supporting a diagnosis of a risk of cancer recurrence is disclosed. The method provides a new determining value a recurrence risk score (RRS) which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The risk of cancer recurrence is judged by comparing the RRS with a predetermined threshold level for RRS.
Claims20
A method supporting a diagnosis of a risk of cancer recurrence, comprising:
- measuring in a malignant tumor sample collected from a patient an expression level of a first cyclin dependent kinase (CDK), an activity value of the first CDK, an expression level of a second CDK and an activity value of the second CDK from a malignant tumor collected from a cancer patient to be examined;
- calculating a recurrence risk score by a first formula comprising
- recurrence risk score=F(X)×G(Y),
- wherein X represents a first CDK specific activity which is a ratio of the activity value of the first CDK to the expression level of the first CDK,
- wherein Y represents a specific activity ratio which is a ratio of a second CDK specific activity to the first CDK specific activity,
- wherein the second CDK specific activity is a ratio of the expression level of the second CDK to the activity value of the second CDK,
- wherein F(X) is a function of a correlation of X with a cancer recurrence rate, and
- wherein G(Y) is a function of a correlation of Y with the cancer recurrence rate.
A method supporting a diagnosis of a risk of cancer recurrence, comprising:
- measuring in a malignant tumor sample collected from a patient an expression level of a first cyclin dependent kinase (CDK), an activity value of the first CDK, an expression level of a second CDK and an activity value of the second CDK from a malignant tumor collected from a cancer patient to be examined;
- calculating a first CDK specific activity which is calculated by using a ratio of the expression level and the activity value of the first CDK, and a second CDK specific activity which is calculated by using a ratio of the expression level and the activity value of the second CDK;
- and
- displaying a recurrence risk judgment graph which comprises at least two parameters of a first CDK specific activity and a second CDK specific activity, and is divided into zones different in a recurrence risk score calculated by a fourth formula comprising
- recurrence risk score=F(X)×G(Y),
- wherein the cancer patients to be examined are plotted based on the first CDK specific activity and the second CDK specific activity on the judgment graph,
- wherein X represents a first CDK specific activity;
- wherein Y represents a specific activity ratio which is a ratio of the first CDK specific activity to the second CDK specific activity,
- wherein F(X) is a function of a correlation of X with a cancer recurrence rate, and
- wherein G(Y) is a function of a correlation of Y with the cancer recurrence rate.
A device supporting a diagnosis of a risk of cancer recurrence, comprising:
- measurement section measuring a malignant tumor collected from a cancer patient to be examined to acquire an expression level of a first cyclin dependent kinase (CDK), an activity value of the first CDK, an expression level of a second CDK and an activity value of the second CDK;
- and
- a controller including a memory under control of a processor, the memory storing instructions enabling the processor to carry out operations which comprise calculating a recurrence risk score by a fifth formula comprising
- recurrence risk score=F(X)×G(Y),
- wherein X represents a first CDK specific activity which a ratio of the activity value of the first CDK to the expression level of the first CDK;
- wherein Y represents a specific activity ratio which is a ratio of a second CDK specific activity to the first CDK specific activity,
- wherein the second CDK specific activity is a ratio of the expression level of the second CDK to the activity value of the second CDK,
- wherein F(X) is a function of a correlation of X with a cancer recurrence rate, and
- wherein G(Y) is a function of a correlation of Y with the cancer recurrence rate.
A device supporting a diagnosis of a risk of cancer recurrence, comprising:
- measurement section measuring a malignant tumor collected from a cancer patient to be examined to acquire an expression level of a first cyclin dependent kinase (CDK), an activity value of the first CDK, an expression level of a second CDK and an activity value of the second CDK;
- and
- a controller system including a display and a memory under control of a processor, the memory storing instructions enabling the processor to carry out operations, comprising:
- calculating a first CDK specific activity which is calculated by using a ratio of the expression level and the activity value of the first CDK acquired by the measurement section, and a second CDK specific activity which is calculated by using a ratio of the expression level and the activity value of the second CDK acquired by the measurement section;
- and
- displaying a recurrence risk judgment graph which comprises at least two parameters of a first CDK specific activity and a second CDK specific activity, and is divided into zones different in a recurrence risk score calculated by an eighth formula comprising
- recurrence risk score=F(X)×G(Y),
- wherein the cancer patients to be examined are plotted based on the first CDK specific activity and the second CDK specific activity on the judgment graph,
- wherein X represents a first CDK specific activity;
- wherein Y represents a specific activity ratio which is a ratio of the first CDK specific activity to the second CDK specific activity,
- wherein F(X) is a function of a correlation of X with a cancer recurrence rate, and
- wherein G(Y) is a function of a correlation of Y with the cancer recurrence rate.
Dependencies are inferred from the claim text.